New hope for advanced breast cancer: maintenance therapy trial launches
NCT ID NCT07179939
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 30 times
Summary
This study tests whether a combination of targeted drugs and hormone therapy can keep advanced HER2-positive breast cancer under control after an initial powerful treatment. About 288 women with cancer that has spread or cannot be removed will receive different maintenance therapies based on their hormone receptor status. The goal is to see how long the cancer stays stable and to monitor side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fudan University
Shanghai, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.